-+ 0.00%
-+ 0.00%
-+ 0.00%

Achieve Life Sciences names Andrew Goldberg CEO, adds him to board

PUBT·04/16/2026 12:57:29
Listen to the news
Achieve Life Sciences names Andrew Goldberg CEO, adds him to board
  • Achieve Life Sciences appointed Andrew D. Goldberg as chief executive officer and board member, effective following closing of recently announced financing.
  • Goldberg most recently served as a portfolio manager at Marshall Wace, previously worked as a partner at Vivo Capital.
  • Richard Stewart stepped down as president and CEO, retaining a board seat.
  • Board expanded with Lucian Iancovici of TPG and Aaron E. Royston of venBio, effective upon financing close.
  • Financing outlined at up to $354 million, including $180 million upfront with $174 million tied to milestone warrant exercises.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604160857PRIMZONECNPR____9691308) on April 16, 2026, and is solely responsible for the information contained therein.